IB Acquisition Corp. Secures $16.5M in Private Placement Ahead of GNQ Insilico Merger
At a glance
- IB Acquisition Corp. raised US$16,470,588 in a private placement.
- Private placement agreements were signed on September 15, 2026.
- The merger with GNQ Insilico is set to create a Nasdaq-listed company.
IB Acquisition Corp. completed a private placement to support its planned acquisition of GNQ Insilico Inc., marking a key step in the companies’ merger process. The transaction is structured to result in GNQ Insilico becoming a publicly traded entity on the Nasdaq Global Market.
The private placement, totaling US$16,470,588, was finalized through agreements entered into on September 15, 2026. This funding is directly linked to the pending business combination between IB Acquisition Corp. and GNQ Insilico Inc.
According to regulatory filings, the details of the private placement were reported in a Form 8-K submitted to the U.S. Securities and Exchange Commission on September 21, 2026. The capital raised is intended to facilitate the completion of the merger and related financial arrangements.
IB Acquisition Corp. and GNQ Insilico Inc. previously entered into a Business Combination Agreement on March 16, 2026. The agreement outlines that IB Acquisition will acquire GNQ Insilico through a statutory plan of arrangement under the Canada Business Corporations Act.
What the numbers show
- US$16,470,588 raised through private placement.
- GNQ Insilico valued at US$500 million in the transaction.
- PIPE financing of up to US$10 million included in the deal.
- Bridge financing of up to US$2 million arranged via convertible notes and warrants.
- Private placement agreements signed on September 15, 2026.
The Business Combination Agreement was announced in a joint press release on March 16, 2026. The announcement stated that the transaction is expected to close in the third quarter of 2026, with GNQ Insilico set to become a publicly listed company on Nasdaq.
The board of directors of IB Acquisition Corp. unanimously approved the Business Combination Agreement and recommended that stockholders vote in favor of the transaction. Upon completion, the combined company will be renamed GNQ Insilico Inc., and its Class A common stock will be listed on the Nasdaq Global Market under the symbol “GNQI.”.
The transaction values GNQ Insilico at US$500 million and includes additional financing components such as a private investment in public equity (PIPE) of up to US$10 million and bridge financing of up to US$2 million. These arrangements involve convertible promissory notes and warrants as part of the funding structure.
Regulatory filings and public disclosures have outlined the procedural steps taken by both companies to advance the merger. The process includes board approval, formal agreements, and required filings with the U.S. Securities and Exchange Commission.
* This article is based on publicly available information at the time of writing.